JOHN VRACIU: Open Payments
NPI 1962638239 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 119 payments from 20 companies in 2025. Trend: 2023 $1,760 · 2024 $2,137 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $334 |
| Alkermes, Inc. | 14 | $251 |
| Indivior Inc. | 18 | $197 |
| Otsuka America Pharmaceutical, Inc. | 9 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $177 |
| Corium, LLC | 13 | $170 |
| Axsome Therapeutics, Inc. | 4 | $109 |
| Braeburn Inc. | 4 | $94 |
| Collegium Pharmaceutical, Inc. | 4 | $89 |
| Supernus Pharmaceuticals, Inc. | 3 | $78 |
Products named: VRAYLAR, ARISTADA, SUBLOCADE, REXULTI, CAPLYTA, Azstarys, Auvelity, BRIXADI.
Industry payments across OH — which companies pay providers there.
